PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

doi:10.1007/s12094-025-04048-z

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico - 1 Mar 2026

Sánchez Cánovas Manuel, López Robles Javier, García Verdejo Francisco José, Cacho Lavin Diego, Olivares Helena, Garrido Fernández Alberto, Coma Salvans Eva, Quintanar Verduguez Teresa, Salvador Coloma Carmen, Fernández Garay David, Cumplido José David, Ferrer Pérez Ana Isabel, Carbó Bagué Anna, Teigell Muñoz Francisco Javier, García López Ruben, Martínez Marin Andrea, Muñoz Martín Andrés J

Abstract excerpt

PURPOSE: To determine the real-world incidence and predictive factors for venous and arterial thromboembolic events (VTE/AT) in ovarian cancer patients treated with poly-(ADP-ribose) polymerase inhibitors (iPARP). METHODS/PATIENTS: A multicenter retrospective study involving 329 ovarian cancer patients who initiated iPARP treatment between January 2015 and December 2022. The primary outcome was the incidence of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bevacizumab

Share to BRCA2 Protein

Share to Incidence

Share to Ovarian Neoplasms

Share to Poly(ADP-ribose) Polymerase Inhibitors

Share to Spain

Share to Thrombosis

Source

Open in PubMed Open full text

Identifiers

PMID: 40914929
DOI: 10.1007/s12094-025-04048-z
PMCID: PMC12920302

Genes

BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PARP inhibitors-associated thrombosis in patients with ovarian cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.PMID 40914929Read ↗

Molecular Correlates of Venous Thromboembolism (VTE) in Ovarian CancerSemantic proximity Read ↗

Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian CancerSemantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.Semantic proximity Read ↗

PARP Inhibitors in the Management of Ovarian Cancer: ASCO GuidelineSemantic proximity Read ↗

Cancer-associated thrombosis in the era of precision oncology: Mechanisms, challenges and future directions.Semantic proximity Read ↗

[Analysis of risk factors for thromboembolism in patients with JAK2V617F gene mutation positive myeloproliferative neoplasms].Semantic proximity Read ↗

Clinical Phenotypes and Prognosis in Patients with Venous Thromboembolism and Cancer: A Cluster AnalysisSemantic proximity Read ↗

Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients.Semantic proximity Read ↗

MicroRNAs as prognostic biomarkers for (cancer–associated) venous thromboembolismSemantic proximity Read ↗

Incidence and Risk Factors for Postoperative Venous Thromboembolism in Patients with Endometrial Cancer: Systematic Review and Meta-analysisSemantic proximity Read ↗

Venous thromboembolism and ovarian cancer risk: a Mendelian randomized studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.